NCT02328040View on ClinicalTrials.gov

Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Placebo and Insulin monotherapy via CL

In the control arm patient receives a placebo pill with the closed loop with insulin/novolog (placebo and insulin/novolog via CL)

DRUG

Sitagliptin and insulin/novolog via CL

In the treatment arm the participant receives a single dose of sitagliptin with closed loop with insulin/novolog (Sitagliptin and insulin/novolog via CL), Part B

Trial Locations (1)

10461

Albert Einstein College of Medicine CRC, The Bronx

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Albert Einstein College of Medicine

OTHER